Auteur/autrice : oxeltis

Oxeltis is a sponsor of next IRT meeting in Stockholm (Aug 28-31, 2022) . Book a meeting with Oxeltis scientists and Visit our booth!

Oxeltis will be present at the 37th ACS National Medicinal Chemistry Symposium in NY June 26-29th. We are very happy to meet you soon, come and visit our poster booth#1 (...)

Grant will fund three-year EPIGENEXT joint project aimed at developing first-in-class therapy for diffuse large B-cell lymphoma Oss, the Netherlands and Montpellier, France, June 8, 2022 – Lead Pharma, a (...)

Organized by the Asian Federation for Medicinal Chemistry (AFMC), AIMECS 2021 (AFMC International Medicinal Chemistry Symposium 2021) is a major event in medicinal chemistry in Asia.Oxeltis, a medicinal chemistry service (...)

Oxeltis is happy to participate and sponsor IS3NA-IRT 2021 Virtual meeting. Looking forward contacting you about your nucleos(t)ides medchem and custom synthesis programs.   https://www.is3na.org/events-1/2021-virtual-symposium

Oxeltis est heureux de participer et de sponsoriser le GECO 2021. Retrouvez-nous pour tous besoins de ressources externes sur vos programmes de chimie médicinale et de synthèse à façon. https://geco61.sciencesconf.org/

Oxeltis' scientists are participating to RICT 2021, lets connect and interact ! Why not planning a virtual meeting at contact@oxeltis.com https://www.rict2021.org/

https://resiconference.com Connect with Oxeltis at Resi Conference, 8-10 June 2021  #medicinalchemistry #smallmolecules #antivirals #medchemservices #networkinghttps://resiconference.com

Dr Stéphane Salamone and Dr Olivier Lavergne will be instrumental in boosting additional lab and medchem capabilities at the company Montpellier, France, November 9, 2020 – Oxeltis, a medicinal chemistry (...)

At Oxeltis, we are committed to continuing our medicinal chemistry research services during the Sars-Cov 2 outbreak, with respect to our staff’s safety and in accordance with the rules put in (...)